Multidrug resistance: Molecular mechanisms and clinical relevance

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 40, Issue , 1997, Pages

  Ling, Victor ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

ABC transporters; Anticancer drugs; Multidrug resistance (MDR); P glycoprotein

Indexed keywords

ABC TRANSPORTER; CYCLOSPORIN A; GLYCOPROTEIN P; VERAPAMIL;

CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; TUMOR CELL;

EID: 0030738677     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051053     Document Type: Conference Paper

References (36)

1. Beck TW, Danks MK, Wolverton JS, Kim R, Chen M (1993) Drug resistance associated with altered DNA topoisomerase II. Adv Enzyme Regul 33:113
2. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Adreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Wamke R, Weinstein R (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 56:3010
3. Borst P, Schinkel AH (1996) What have we learnt thus far from mice with disrupted P-glycoprotein genes? Eur J Cancer 32a:985
4. Bradley G, Ling V (1994) P-glycoprotein multidrug resistance, and tumor progression. Cancer Metastasis Rev 13:223
5. Chan HSL, Canton MD, Gallie BL (1989) Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines. Anticancer Res 9:469
6. Chan HSL, Thorner P, Haddad G, Ling V (1990) Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689
7. Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, Yeger H, Ling V (1991) P-glycoprotein as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325:1608
8. Chan HSL, Thorner PS, Haddad G, DeBoer G, Ling V (1993) Multidrug resistance in sarcomas of children. In: Novak JF, McMaster JH (eds) Frontiers of osteosarcoma research. Hogrefe & Huber, Kirkland, WA, p 52
9. Chan HSL, De Boer G, Thiessen JJ, Budning A, Kingston JE, O'Brien JM, Koren G, Griesbrecht E, Haddad G, Verjee Z, Hungerford JL, Ling V, Gallie BL (1996) Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 2:1499
10. Childs S, Ling V (1994) The MDR superfamily of genes and its biological implications. In: DeVita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology. Lippincott, Philadelphia, p 21
11. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650
12. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected tumor cells. Cancer 54:5902
13. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP, Salmon SE (1989) Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:415
14. Georges E, Sharom FJ, Ling V (1990) Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv Pharmacol 21:185
15. Hedley DW, Xie SX-Y, Minden M, Choi CH, Chen H, Ling V (1997) A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia. Leukemia 11:48
16. Ishikawa T (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17:463
17. Ishikawa T, Bao JJ, Yamane Y, Akimaru K, Frindrich K, Wright CD, Kuo MT (1997) Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem (in press)
18. Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, Keppler D (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269:27807
19. List AF, Spier C, Greer J, Wolff S, Hutter J, Dorr R, Salmon S, Futcher B, Baier M, Dalton W (1993) Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 11:1652
20. Ma DD, Davey RA, Harman DH, Isbister JP, Scurr RD, Mackertich SM, Dowden G, Bell DR (1987) Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukemia. Lancet i:135
21. Marie JP (1995) P-glycoprotein in adult hematologic malignancies. Hematol Oncol Clin North Am 9:239
22. Morrow CS, Cowan KH (1990) Glutathione-S-transferases and drug resistance. Cancer Cells 2:15
23. Pirker R, Wallner J, Greissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Schemer R, Valent P, Havelec L, Ludwig H, Lechner K (1991) MDRI gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83:708
24. Reed JC (1995) BCL-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9:451
25. Sato H, Preisler H, Day R, Raza A, Larson R, Browman G, Goldberg J, Vogler R, Grunwald H, Gottlieb A, Bennett J, Gottesman MM, Pastan I (1990) MDR1 transcript level as an indication of resistant disease in acute myelogenous leukemia. Br J Haematol 75:340
26. Savaraj N, Chun MD, Wu J, Xu R, Lampidis T, Lai S, Donnelly E, Solomon J, Feun LG (1997) Multidrug resistant gene expression in small cell lung cancer. Am J Oncol (in press)
27. Schinkel AH, Smit JJM, Tellingen O van, Beijen JH, Wagenaar E, Deemter L van, Mol CAAM, Valk A van der, Robanus-Maandag EC, Riele HPJ te, Berns AJM, Borst P (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491
28. Schinkel AH, Wagenaar E, Deemter L van, Mol CAAM, Borst P (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J Clin Invest 96:1698
29. Schuurhuis GJ, Broxterman HJ, Ossenkoppele GJ, Beak JPA, Eekman CA, Kuiper CM, Feller N, Heijningen THM van, Klumper E, Pieters R, Lankelma J, Pinedo HM (1995) Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin Cancer Res 1:81
30. See YP, Carlsen SA, Till JE, Ling V (1994) Increased drug permeability in Chinese hamster ovary cells in the presence of cyanide. Biochim Biophys Acta 373:242
31. Shapiro A, Ling V (1995) Using purified P-glycoprotein to understand multidrug resistance. J Bioenerg Biomembr 27:7
32. Sheps JA, Zhang F, Ling V (1996) Bacterial toxin transport. Membr Prot Transport 3:81
33. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, Deemter L van, Mol CAAM, Ottenhoff R, Lugt NMT van der, Roon MA van, Valk MA van der, Offerhaus GJA, Bems AJM, Borst P (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451
34. Sonneveld P, Durie BGM, Lokhorst HK, Marie JM, Solbu G, Suciu S, Zittoun R, Lowenberg B, Nooter K (1992) Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet 340:255
35. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967
36. Zhou DC, Ramond S, Viguie F, Faussat AM, Zittoun R, Marie JP (1996) Sequential emergence of MRP and MDRI gene overexpression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines. Int J Cancer 65:365